ATE532867T1 - B-zellen-toleranzinduktion - Google Patents

B-zellen-toleranzinduktion

Info

Publication number
ATE532867T1
ATE532867T1 AT08837232T AT08837232T ATE532867T1 AT E532867 T1 ATE532867 T1 AT E532867T1 AT 08837232 T AT08837232 T AT 08837232T AT 08837232 T AT08837232 T AT 08837232T AT E532867 T1 ATE532867 T1 AT E532867T1
Authority
AT
Austria
Prior art keywords
induction
production
cell
tolerance induction
cell tolerance
Prior art date
Application number
AT08837232T
Other languages
English (en)
Inventor
Thierry Vandendriessche
Marinee Chuah
Jean-Marie Saint-Remy
Marc Jacquemin
Original Assignee
Vib Vzw
Life Sciences Res Partners Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vib Vzw, Life Sciences Res Partners Vzw filed Critical Vib Vzw
Application granted granted Critical
Publication of ATE532867T1 publication Critical patent/ATE532867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/13—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4238—Regulators of development
    • A61K40/4239—Cell cycle regulated proteins, e.g. cyclin, CDC, CDK or INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08837232T 2007-10-08 2008-10-08 B-zellen-toleranzinduktion ATE532867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97834307P 2007-10-08 2007-10-08
PCT/EP2008/063477 WO2009047270A2 (en) 2007-10-08 2008-10-08 B cell tolerance induction

Publications (1)

Publication Number Publication Date
ATE532867T1 true ATE532867T1 (de) 2011-11-15

Family

ID=40158643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08837232T ATE532867T1 (de) 2007-10-08 2008-10-08 B-zellen-toleranzinduktion

Country Status (5)

Country Link
US (1) US20100322967A1 (de)
EP (1) EP2205742B1 (de)
AT (1) ATE532867T1 (de)
CA (1) CA2701739A1 (de)
WO (1) WO2009047270A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9669057B2 (en) 2008-04-25 2017-06-06 Duke University Regulatory B cells and their uses
WO2011147622A1 (en) * 2010-05-26 2011-12-01 Deutsches Rheuma-Forschungszentrum Berlin Antigen-presenting modified naïve b cells for immune suppression and a method for producing said modified cells
US10017739B2 (en) 2012-09-06 2018-07-10 Duke University Methods of expanding and assessing B cells and using expanded B cells to treat disease
WO2014198717A1 (en) * 2013-06-11 2014-12-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for obtaining a population of interleukin 10-secreting b cells

Also Published As

Publication number Publication date
EP2205742B1 (de) 2011-11-09
EP2205742A2 (de) 2010-07-14
WO2009047270A3 (en) 2009-07-09
US20100322967A1 (en) 2010-12-23
CA2701739A1 (en) 2009-04-16
WO2009047270A2 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
MX2020000957A (es) Anticuerpos anti-sirp-alfa y metodos relacionados.
CY1121911T1 (el) Cd47 αντισωματα και μεθοδοι χρησης αυτων
MX2011011925A (es) Anticuerpos triespecificos o tetraespecificos.
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
WO2010088633A3 (en) Novel cell lines and methods
EA201590209A1 (ru) Применение cart19 для истощения нормальных b-клеток для индукции толерантности
WO2013177429A3 (en) Extreme pcr
BR112013018311A2 (pt) sequência de ácido nucleico isolada, receptor de antígeno quimérico isolado, célula t geneticamente modificada, vetor, e, uso de uma célula t geneticamente modificada.
EP2808393A3 (de) Fucosylierungsunfähige Zellen
ATE520131T1 (de) Aluminiumpasten und ihre verwendung bei der herstellung von silicium-solarzellen
GB201314557D0 (en) Borehole metal member bonding system and method
SG194480A1 (en) Method of forming membranes with modified stress characteristics
WO2009102569A3 (en) Cell lines and methods for making and using them
TR201903001T4 (tr) Dökme poliamidlerin üretilmesine yönelik yöntem.
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MX346146B (es) Metodo para detectar un aglutinante multiespecifico.
ATE532867T1 (de) B-zellen-toleranzinduktion
WO2012058637A3 (en) Antisera assays for mlv related viruses in humans and other mammals
EA201270577A1 (ru) Усовершенствованные способы обратной генетики для спасения вирусов
GB201020671D0 (en) Passive immunotherapy
EP2262834A4 (de) Antikörper als t-zellen-rezeptor-mimetika, herstellungsverfahren und ihre verwendungen
IT1400343B1 (it) Gruppo elettrogeno, particolarmente per caricabatterie.
MX2015004892A (es) Metodos y composiciones que se relacionan con anticuerpos de receptor anti-il-21.
TR201102466U (tr) Kompozit tuğlalar.